WRLD has Key Breakout Point of $0.87

International Cannabis Corp (CSE: WRLD) closed yesterday up $0.02 to $0.81 per share on HUGE volume of 2,325,584 shares and has a key breakout point of $0.87 per share. After WRLD surpasses $0.87 per share, we believe it will quickly explode north of $1 per share.

On September 17th, Auxly Cannabis Group Inc (TSXV: XLY) - a $637 million market cap cannabis company led by Chuck Rifici the founder of the world's largest cannabis company Canopy Growth (CGC), invested $5 million into WRLD. This is an extremely bullish sign that WRLD is well on its way to becoming a major international cannabis conglomerate similar to CGC.

Since June, WRLD has acquired seven major international cannabis companies:

Marathon Global: has an exclusive agreement with Cosmos Holdings Inc. a European based pharmaceutical distributor, to procure and distribute medical cannabis products and all cannabis derivatives for clients of Cosmos in approved countries within its distribution network of 110 clients, representing approximately 35,000 pharmacies in 16 countries.

CanAfrica  Holdings: holds a license to cultivate, manufacture, supply, hold, import, export and transport cannabis and derivative products in the Kingdom of Lesotho, Africa.

Canna Colombia Holdings Inc: holds Colombian licences to cultivate, produce, hold, sell and export cannabis and its by-products.

EU Cannabis Corp: is in the final stages of the application process for a Greek medical Cannabis licence. It controls a 13-acre land package situated in Northern Greece, which upon receipt of the medicinal Cannabis licence will be dedicated to medical grade Cannabis cultivation, extraction, distribution, as well as research and development.

Farmakem: a revenue generating, licensed, medical cannabis company based in Slovenia. Its focus is on research and development, production, supply, distribution and commercialisation of active pharmaceutical ingredients, medical devices and food supplements within the medical cannabis/hemp industry. Farmakem has obtained licences for the international wholesale, import and export of more than 150 APIs (including CBD and some narcotics and psychoactive substances), medical devices and food supplements. It is the first company in Slovenia to obtain approval to import medicinal cannabis and delta 9 Tetrahydrocannabinol (THC) of natural origin.

Aricannabis: has an exclusive deal with NuCare Health to provide Cannabis products to more than 2,800 independent and corporate pharmacies across South Africa.

Danavian Cannabis Ltd: controls 1 of only 12 highly coveted licences for cannabis cultivation in the Kingdom of Denmark.

Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA has received compensation from WRLD of $35,000 cash for a 15-day investor relations contract and expects to receive an additional $35,000 cash for an additional 15-day investor relations contract for a total of $70,000 cash. Never make investment decisions based on anything NIA says. This message is meant for informational and educational purposes only and does not provide investment advice.